Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)
In obesity, discussions often focus on side effects, weight trajectories, and the importance of persistence
Akopyan represented Novo Nordisk in the patent filing
But she said her clinic has already begun preparing by adding providers and identifying patients who may qualify for the program
As of July 2026, Ro has fully exited compounded GLP-1s and sells only FDA-approved branded medication: Wegovy oral pill at $149/month for the first month, rising to $199$299/month at higher ongoing doses
Advertisement Supported by Costco to Sell Popular Weight-Loss Drugs Ozempic and Wegovy Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturers direct-to-consumer website
